6190 — PhoenixBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥2bn
- ¥1bn
- ¥2bn
- 25
- 57
- 19
- 21
Annual cashflow statement for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -295 | -418 | -224 | -393 | 511 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.41 | 275 | -24.1 | 263 | 10.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 74 | 44.7 | 90.6 | 60 | -267 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -160 | -12.6 | -102 | 16.4 | 277 |
| Capital Expenditures | -65.5 | -30.6 | -182 | -6.77 | -12.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.904 | 14.9 | -2.46 | -0.204 | -144 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -64.6 | -15.8 | -185 | -6.97 | -156 |
| Financing Cash Flow Items | — | 0.912 | — | — | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -64.7 | 1,146 | -160 | -34.7 | 86.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -276 | 1,119 | -448 | -2.31 | 230 |